# Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis

> **NCT01357538** · PHASE4 · COMPLETED · sponsor: **Ursapharm Arzneimittel GmbH** · enrollment: 197 (actual)

## Conditions studied

- Blepharitis
- Signs and Symptoms

## Interventions

- **DRUG:** Posiformin 2 %, bibrocathol
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01357538
- **Lead sponsor:** Ursapharm Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2011-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357538, "Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01357538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*